1. AB1267 Bio-similar to bio-originator switchback: not a reliable quality indicator. (12th June 2018) Authors: Lee, S.Y.; Szeto, M.C.H.; Galloway, J.B. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1727 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Describing the burden of the COVID‐19 pandemic in people with psoriasis: findings from a global cross‐sectional study. (19th August 2021) Authors: Mahil, S.K.; Yates, M.; Yiu, Z.Z.N.; Langan, S.M.; Tsakok, T.; Dand, N.; Mason, K.J.; McAteer, H.; Meynell, F.; Coker, B.; Vincent, A.; Urmston, D.; Vesty, A.; Kelly, J.; Lancelot, C.; Moorhead, L.; Bachelez, H.; Capon, F.; Contreras, C.R.; De La Cruz, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 10(2021) Page Start: e636 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0146 The risk of gastrointestinal perforations in patients with rheumatoid arthritis treated with anti-TNF therapy - results from the british society for rheumatology biologics register (BSRBR). (23rd January 2014) Authors: Zavada, J.; Lunt, M.; Davies, R.; Low, A.S.; Mercer, L.K.; Galloway, J.B.; Watson, K.D.; Symmons, D.P.; Hyrich, K. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Risk‐mitigating behaviours in people with inflammatory skin and joint disease during the COVID‐19 pandemic differ by treatment type: a cross‐sectional patient survey. (1st July 2021) Authors: Mahil, S.K.; Yates, M.; Langan, S.M.; Yiu, Z.Z.N.; Tsakok, T.; Dand, N.; Mason, K.J.; McAteer, H.; Meynell, F.; Coker, B.; Vincent, A.; Urmston, D.; Vesty, A.; Kelly, J.; Lancelot, C.; Moorhead, L.; Bachelez, H.; Bruce, I.N.; Capon, F.; Contreras, C.R. Journal: British journal of dermatology Issue: Volume 185:Number 1(2021) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Risk‐mitigating behaviours in people with inflammatory skin and joint disease during the COVID‐19 pandemic differ by treatment type: a cross‐sectional patient survey. (9th March 2021) Authors: Mahil, S.K.; Yates, M.; Langan, S.M.; Yiu, Z.Z.N.; Tsakok, T.; Dand, N.; Mason, K.J.; McAteer, H.; Meynell, F.; Coker, B.; Vincent, A.; Urmston, D.; Vesty, A.; Kelly, J.; Lancelot, C.; Moorhead, L.; Bachelez, H.; Bruce, I.N.; Capon, F.; Contreras, C.R. Journal: British journal of dermatology Issue: Volume 185:Number 1(2021) Page Start: 80 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0148 Does depression affect response to anti-tumour necrosis factor-α therapy in patients with rheumatoid arthritis (RA)? Results from the british society for rheumatology biologics register (BSRBR). (23rd January 2014) Authors: Davies, R.; Mercer, L.K.; Galloway, J.B.; Low, A.S.; Watson, K.D.; Lunt, M.; Symmons, D.P.; Hyrich, K.L. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SAT0150 Optimising Treatment with TNF Inhibitors in Rheumatoid Arthritis with Different Dose Tapering Strategies: The Opttira Trial. (9th June 2015) Authors: Galloway, J.B.; Kingsley, G.; Ma, M.; Lorente-Canovas, B.; Cope, A.; Ibrahim, F.; Scott, D.L. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 706 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗